Annual Total Liabilities
$97.64 M
-$129.19 M-56.95%
December 1, 2024
Summary
- As of March 12, 2025, TRDA annual total liabilities is $97.64 million, with the most recent change of -$129.19 million (-56.95%) on December 1, 2024.
- During the last 3 years, TRDA annual total liabilities has risen by +$90.53 million (+1272.35%).
- TRDA annual total liabilities is now -56.95% below its all-time high of $226.83 million, reached on December 31, 2023.
Performance
TRDA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$97.64 M
-$34.50 M-26.11%
December 1, 2024
Summary
- As of March 12, 2025, TRDA quarterly total liabilities is $97.64 million, with the most recent change of -$34.50 million (-26.11%) on December 1, 2024.
- Over the past year, TRDA quarterly total liabilities has stayed the same.
- TRDA quarterly total liabilities is now -65.99% below its all-time high of $287.07 million, reached on June 30, 2023.
Performance
TRDA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TRDA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.0% | 0.0% |
| 3 y3 years | +1272.3% | +147.2% |
| 5 y5 years | +189.3% | +147.2% |
TRDA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.0% | +1272.3% | -66.0% | +1272.3% |
| 5 y | 5-year | -57.0% | +1272.3% | -66.0% | +1272.3% |
| alltime | all time | -57.0% | +1272.3% | -66.0% | +1272.3% |
Entrada Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $97.64 M(-57.0%) | $97.64 M(-26.1%) |
| Sep 2024 | - | $132.14 M(-13.1%) |
| Jun 2024 | - | $152.04 M(-37.0%) |
| Mar 2024 | - | $241.48 M(+6.5%) |
| Dec 2023 | $226.83 M(+474.2%) | $226.83 M(-4.8%) |
| Sep 2023 | - | $238.37 M(-17.0%) |
| Jun 2023 | - | $287.07 M(+16.7%) |
| Mar 2023 | - | $245.96 M(+522.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $39.50 M(+455.2%) | $39.50 M(-4.2%) |
| Sep 2022 | - | $41.24 M(+3.4%) |
| Jun 2022 | - | $39.88 M(+1.4%) |
| Mar 2022 | - | $39.31 M(+452.5%) |
| Dec 2021 | $7.12 M(-91.6%) | $7.12 M(-96.5%) |
| Sep 2021 | - | $204.99 M(+1.2%) |
| Jun 2021 | - | $202.53 M(+138.2%) |
| Dec 2020 | $85.02 M(+151.9%) | $85.02 M |
| Dec 2019 | $33.76 M | - |
FAQ
- What is Entrada Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics annual total liabilities year-on-year change?
- What is Entrada Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly total liabilities year-on-year change?
What is Entrada Therapeutics annual total liabilities?
The current annual total liabilities of TRDA is $97.64 M
What is the all time high annual total liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total liabilities is $226.83 M
What is Entrada Therapeutics annual total liabilities year-on-year change?
Over the past year, TRDA annual total liabilities has changed by -$129.19 M (-56.95%)
What is Entrada Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TRDA is $97.64 M
What is the all time high quarterly total liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total liabilities is $287.07 M
What is Entrada Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TRDA quarterly total liabilities has changed by $0.00 (0.00%)